Bill Smith, MD
Sports Medicine · Chattanooga, TNNPI 1003881061
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $2,978 of the $4,747 with a category attached, or 62.7%. AbbVie accounts for 65.9% of it on its own, with 27 other manufacturers making up the rest. Reporting peaked in 2021 at $3,338 and has fallen 88.2% since, to $393 in 2025.
Across 101 payments — averaging $47.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Ferring Pharmaceuticals Inc.$397
- Novo Nordisk$214
- Abbott$152
- Globus Medical$98
- Pacira Pharmaceuticals Incorporated$97
- plus $660 from 22 others
Across 12 payments — averaging $24,430 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biocryst Pharmaceuticals, Inc.$293K
What the payments were for
- Speaking & faculty fees$2,97863%
- Food & beverage$1,77037%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 10 | $3,128 |
| Ferring Pharmaceuticals Inc. | 27 | $397 |
| Novo Nordisk | 13 | $214 |
| Abbott | 8 | $152 |
| Globus Medical | 1 | $98 |
| Pacira Pharmaceuticals Incorporated | 4 | $97 |
| Amgen(2 entities) | 4 | $66 |
| DJO, LLC | 2 | $63 |
| Linvatec Corporation | 4 | $59 |
| Pacira Therapeutics, Inc. | 2 | $57 |
| Jazz Pharmaceuticals Inc. | 3 | $42 |
| Seqirus USA Inc | 2 | $39 |
| AstraZeneca | 2 | $31 |
| Avanos Medical | 2 | $29 |
| Kowa Pharmaceuticals America, Inc. | 2 | $25 |
| Fidia Pharma USA Inc. | 2 | $25 |
| Mallinckrodt Hospital Products Inc. | 1 | $24 |
| Curonix LLC | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Nevro Corp. | 1 | $20 |
| Alpha Orthopedic Systems | 1 | $20 |
| Zimmer Biomet | 1 | $19 |
| Orthofix Medical, Inc. | 2 | $18 |
| Boston Scientific | 1 | $18 |
| Medtronic | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Smith+Nephew | 1 | $15 |
| Bioventus LLC | 1 | $14 |
How this compares
$4,747 in reported general payments places this provider in the 60th percentile of 147 sports medicine providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisone | 53 | $862 |
| Rosuvastatin Calcium | 24 | $336 |
| Gabapentin | 30 | $255 |
| Simvastatin | 31 | $254 |
| Losartan Potassium | 15 | $241 |
| Clonazepam | 14 | $205 |
| Benazepril Hcl | 35 | $202 |
| Meloxicam | 82 | $174 |
| Lisinopril | 13 | $108 |
| Methylprednisolone | 22 | $96 |
| Methocarbamol | 42 | $91 |
| Amlodipine Besylate | 12 | $30 |
| Tizanidine Hcl | 12 | $29 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Chattanooga
- Brandon CincereChattanooga$22K
- Benjamin MillerChattanooga$20K
- Chad SmalleyChattanooga$6K
- Jeffrey DlabachCollierville$504K
- Ian ByramFranklin$252K
- Jw ByrdNashville$248K
- Lucas RichieLebanon$159K
- Zachary PharrColumbia$75K
- Colin LooneyFranklin$68K
- Jonathan BryantBristol$67K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.